企業プロフィール
ThermoGenesis 株価・ニュース・カタリスト
- ティッカー:
- THMO
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (-99.00%)
終値
最終更新: 2026年8月4日
—
時価総額
株価変動の要因
Current closing-price context is not available for THMO.
企業概要
事業概要
ThermoGenesis was a biotechnology company focused on cell processing, cell banking, and manufacturing systems for regenerative medicine. Its business sat at the intersection of tools, services, and cell-therapy enablement.
所在地とセクター分類
ThermoGenesis was headquartered in the United States and listed on NASDAQ. It sat in biotechnology tools and cell-processing infrastructure.
ビジネスモデルの特徴
The company depended on platform adoption, manufacturing workflow demand, and the ability to monetize cell-processing technology. Investors historically watched commercial traction and strategic changes.
バイオ業界での位置付け
ThermoGenesis belongs in the cell-processing infrastructure layer of biotech. It is not a classic drug stock, but it supported the manufacturing ecosystem around regenerative medicine.
今後のカタリスト
- ThermoGenesis is largely a legacy and closeout story now, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like a fresh growth name.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。